Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
11 Cards in this Set
- Front
- Back
|
Albuterol |
Class: Sympathomimetic Dose: 2.5mg in 3 ml fluid NEB Uses: Treat reversible Bronchoconstriction MOA: Some Beta 1 stimulation, little to no Alpha stimulation S/E: headache, nervousness, sweating, anxiety, dizziness, tachycardia, hypertension, palpations. C/I: Hypertension, Vomiting, Cardiovascular disorders, tachycardia arrhythmia's caused by digitalis; synergistic effect with other sympathomimetic |
|
|
Atropine |
Class: Sympathomimetic Dose: Brady: 0.5 mg FIVP OGP: 1-2 mg IVP Uses: Sinus Bradycardia, Asystole and PEA; signs of OGP MOA: Blocks acetylcholine receptor sites so the PNS can not be activated S/E: Restlessness, agitation, diaphoresis, headache, anxiety, dizziness, arrhythmias and paradoxical bradycardia. C/I: ABSOLUTE: Acute myocardial infarction, tachycardia |
|
|
Diazepam |
Valium Class: Benzodiazepine; sedative Dose: 2-20mg SIVP Use: Seizures/ Status epi, Sedation prior to RSI MOA: Suppresses spread of Seizure activity and raises seizure threshold. S/E: drowsiness, fatigue, headache, hypotension, reflex tachycardia, respiratory arrest/depression, increased ICP C/I: Head injury, coma, shock, respiratory depression/ arrest |
|
|
Diltiazem Hydrochloride |
Cardizem Class: Benzodiazepine, Class: IV antidysrhythmic Dose: 0.25mg/kg SIVP over 2 minutes Use: A-Fib/flutter with RVR; PSVT MOA: blocks calcium channels decreases SA&AV conduction S/E: Syncope, Tinnitus, dizziness, angina, A-flutter, dyspnea, C/I: |
|
|
Epinephrine |
Class: Sympathomimetic Dose: Asthma/Anaph: 0.3-0.5mg 1:1,000 SQ Cardiac Arrest: 1-2 mg IV Use: Anaphylaxis, asthma, cardiac arrest, Pulseless V-tach and V-fib MOA: naturally occurring chemical that stimulates the sympathetic system S/E: headache, SVT, Arrhythmia; PE; High BS C/I: Uncorrected Tachy; Hypovolemia; hypothermia; high BP |
|
|
Diphenhydramine |
Class: Antihistamine Dose: 25-50 mg SIVP; 50 mg Deep IM Use: allergic reaction with epi; motion sickness MOA: Blocks H1 and H2 receptor stimulation S/E: Drowsiness; fever; headache; dizziness; shortened diastolic which may cause reflex tachycardia; arrhythmias. C/I: Use of Monoamine Oxidase Inhalers (MAOI); Glaucoma; asthmatic attack; nursing mother; infants |
|
|
Morphine |
Class: Opiate; Schedule II narc; CNS agent (depressant) Dose: CP: 1-2mg SIVP; Pain: 0.1mg/kg SIVP Use: Pain; chest pain MOA: binds wiht opiate receptors and changes the way pain is precieved both preception and emotional response. S/E: ALOC; headache; constricted pupils; brady/tachy; resp depression; euporia; syncope. C/I: ALOC; Head injury; Acute Asthma; hypotension/volemia; use of MAOI's Within 14 days; seizure disorders |
|
|
Ondanseton |
Zofran Class: Antiemetic Dose: 4mg SIVP over 30 sec or 4mg IM undiluted Use: vomiting/nausea MOA: not fully understood; blocks chemoreceptors that stimulate vomiting S/E: reflex vomiting if pushed fast; CNS depression; dizziness; malaise; fatigue; chest pain; tachycardia; bronchospasm. C/I: decreased liver function; intestinal obstruction; cardiac arrhythmias. |
|
|
Succinylcholine |
Class: paralytic Dose: 1.0-1.5 mg/kg IVP Use: RSI MOA: depolarizing paralytic binds to site and does not allow chemical to be released that repolarizes the muscle S/E: respiratory depression/arrest; arrhythmias; cardiac arrest; hypertension, increased ICP; bradycardia; sinus arrest; hypotension C/I: penetrating eye injury; head injury; known hyperkalemia; asthma; 7-10 days after severe burn. |
|
|
Rocuronium |
Class: non-depolarizing paralytic Dose: 0.6-1.2 mg/kg IVP MOA: non-depolarizing neuromuscular blocking agent S/E: complete paralysis; hyper/hypotension; tachycardia; increased pulmonary vascular resistance C/I: Known hypersensitivity |
|
|
Dopamine |
Class: sympathomimetic Dose: 2-20 mcg/kg/min; mixture with 200 mg/250ml to yield an 1600 mcg /ml solution MOA: effects on beta-1 causes a positive inotropic (strength of contractions of heart) also acts on alpha-adrenergic receptors causing vasoconstriction in higher doses S/E: headache; tremor; anxiety; angina; tachy; dilated pupils; dyspnea. C/I: CA; hypovolemia; uncorrected/ controlled tachy; phenochromocytoma |
